Crossover Patient Outcomes for Targeted Lung Denervation in Moderate to Severe Chronic Obstructive Pulmonary Disease: AIRFLOW-2
Sign Up to like & getrecommendations! Published in 2022 at "Respiration"
DOI: 10.1159/000527455
Abstract: Background: Targeted Lung Denervation (TLD) is a potential new therapy for COPD. Radiofrequency energy is bronchoscopically delivered to the airways to disrupt pulmonary parasympathetic nerves, to reduce bronchoconstriction, mucus hypersecretion, and bronchial hyperreactivity. Objectives: This… read more here.
Keywords: copd; crossover; lung denervation; airflow crossover ... See more keywords